Cargando…

Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience

BACKGROUND: In recent years, the anti-programmed cell death 1 (PD-1) drug pembrolizumab (Keytruda) was approved for treatment of unresectable advanced non-small cell lung cancer (NSCLC) as first- or second-line therapy depending on the clone 22C3-programmed death-ligand 1 (PD-L1) immunohistochemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeda, Maiko, Kasai, Takahiko, Naito, Maiko, Tamiya, Akihiro, Taniguchi, Yoshihiko, Saijo, Nobuhiko, Naoki, Yoko, Okishio, Kyoichi, Shimizu, Shigeki, Kojima, Kensuke, Nagoya, Akihiro, Sakamoto, Tetsuki, Utsumi, Tomoki, Yoon, Hyung-Eun, Matsumura, Akihide, Atagi, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329032/ https://www.ncbi.nlm.nih.gov/pubmed/30670923 http://dx.doi.org/10.1177/1179554918821314

Ejemplares similares

A High PD-L1 Expression in Pulmonary Pleomorphic Carcinoma Correlates with Parietal-pleural Invasion and Might Predict a Poor Prognosis
por: Naito, Maiko, et al.
Publicado: (2018)

Adenocarcinoma with fetal features invading the right superior sulcus treated with neoadjuvant chemoradiotherapy followed by complete video-assisted thoracoscopic right upper lobectomy: a case report
por: Kojima, Kensuke, et al.
Publicado: (2019)

Enhancing tumour content and tumour cell count using microdissection contributes to higher detection rate of genetic mutations by next-generation sequencers()
por: Tamiya, Akihiro, et al.
Publicado: (2023)

Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status
por: Adachi, Yuichi, et al.
Publicado: (2019)

Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report
por: Inagaki, Yuji, et al.
Publicado: (2020)

Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF‐V600E‐positive non–small cell lung cancer: A case report
por: Taniguchi, Yoshihiko, et al.
Publicado: (2023)

Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
por: ISA, SHUN-ICHI, et al.
Publicado: (2015)

A quantitative evaluation of the histological type dependence of the programmed death-ligand 1 expression in non-small cell lung cancer including various adenocarcinoma subtypes: a cross-sectional study
por: Kojima, Kensuke, et al.
Publicado: (2021)

Right‐sided vocal cord paralysis following stereotactic body radiation therapy for non–small‐cell lung cancer: A case report
por: Kanaoka, Kensuke, et al.
Publicado: (2023)

PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
por: Kojima, Kensuke, et al.
Publicado: (2021)

Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysis
por: Naito, Yujiro, et al.
Publicado: (2017)

Retrospective analysis of long‐term survival factors in patients with advanced non‐small cell lung cancer treated with nivolumab
por: Murakami, Yusuke, et al.
Publicado: (2022)

Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
por: Kanaoka, Kensuke, et al.
Publicado: (2023)

Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report
por: Matsumoto, Kinnosuke, et al.
Publicado: (2021)

The Association of Vacuum-Assisted Closure Therapy with Dynamic Volume Change of a Muscle Flap Transposed in an Empyema Cavity for Chronic Empyema: A Case Report
por: Kojima, Kensuke, et al.
Publicado: (2020)

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
por: Nakao, Keiko, et al.
Publicado: (2019)

Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease
por: Kojima, Kensuke, et al.
Publicado: (2023)

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC
por: Tamiya, Motohiro, et al.
Publicado: (2021)

Improvement of Mycobacterium abscessus Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung Cancer
por: Ishii, Seigo, et al.
Publicado: (2018)

The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
por: Samejima, Hironobu, et al.
Publicado: (2023)

Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study
por: Matsumoto, Kinnosuke, et al.
Publicado: (2021)

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer
por: Shiroyama, Takayuki, et al.
Publicado: (2017)

PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study
por: Kojima, Kensuke, et al.
Publicado: (2022)

Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
por: Kurahara, Yu, et al.
Publicado: (2021)

Lymphoplasmacytic lymphoma involving the mediastinum and the lung, followed by amyloidosis: A surgically and genetically proven case
por: Adachi, Yuichi, et al.
Publicado: (2020)

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
por: Tamiya, Motohiro, et al.
Publicado: (2018)

Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan
por: Ogawa, Koichi, et al.
Publicado: (2020)

Triple Difficulties in Japanese Women with Hearing Loss: Marriage, Smoking, and Mental Health Issues
por: Kobayashi, Yoko, et al.
Publicado: (2015)

Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
por: Kuge, Tomoki, et al.
Publicado: (2023)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
por: Kinehara, Yuhei, et al.
Publicado: (2023)

A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01
por: Atagi, Shinji, et al.
Publicado: (2023)

Successful intervention for overwhelming postsplenectomy infection caused by non-vaccine pneumococcal serotype 23A
por: Kojima, Yuichi, et al.
Publicado: (2020)

Pustular eruption on the palms and soles associated with zinc allergy and perspiration
por: Naito, Yukiko, et al.
Publicado: (2023)

Coexistence of Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis
por: Naito, Maiko, et al.
Publicado: (2017)

Group 2 innate lymphoid cells and their surrounding environment
por: Naito, Maiko, et al.
Publicado: (2023)

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma
por: Tomono, Ayana, et al.
Publicado: (2016)

Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy
por: Kawaguchi, T, et al.
Publicado: (2000)

A Novel Role of the NRF2 Transcription Factor in the Regulation of Arsenite-Mediated Keratin 16 Gene Expression in Human Keratinocytes
por: Endo, Hitoshi, et al.
Publicado: (2008)

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
por: Wang, Rong, et al.
Publicado: (2020)

Metabolic engineering using iterative self-cloning to improve lipid productivity in Coccomyxa
por: Kasai, Yuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2d7loap3o7i0m3rc9qkghr18di